Directly to content
  1. Publishing |
  2. Search |
  3. Browse |
  4. Recent items rss |
  5. Open Access |
  6. Jur. Issues |
  7. DeutschClear Cookie - decide language by browser settings

External validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS

Alwers, Elizabeth ; Bläker, Hendrik ; Walter, Viola ; Jansen, Lina ; Kloor, Matthias ; Arnold, Alexander ; Sieber-Frank, Julia ; Herpel, Esther ; Tagscherer, Katrin E. ; Roth, Wilfried ; Chang-Claude, Jenny ; Brenner, Hermann ; Hoffmeister, Michael

In: BMC Cancer, 19 (2019), Nr. 681. pp. 1-10. ISSN 1471-2407

[img] PDF, English - main document
Download (822kB) | Lizenz: Creative Commons LizenzvertragExternal validation of molecular subtype classifications of colorectal cancer based on microsatellite instability, CIMP, BRAF and KRAS by Alwers, Elizabeth ; Bläker, Hendrik ; Walter, Viola ; Jansen, Lina ; Kloor, Matthias ; Arnold, Alexander ; Sieber-Frank, Julia ; Herpel, Esther ; Tagscherer, Katrin E. ; Roth, Wilfried ; Chang-Claude, Jenny ; Brenner, Hermann ; Hoffmeister, Michael underlies the terms of Creative Commons Attribution 4.0

Citation of documents: Please do not cite the URL that is displayed in your browser location input, instead use the DOI, URN or the persistent URL below, as we can guarantee their long-time accessibility.

Abstract

Background: Competing molecular classification systems have been proposed to complement the TNM staging system for a better prediction of survival in colorectal cancer (CRC). However, validation studies are so far lacking. The aim of this study was to validate and extend previously published molecular classifications of CRC in a large independent cohort of CRC patients.

Methods: CRC patients were recruited into a population-based cohort study (DACHS). Molecular subtypes were categorized based on three previously published classifications. Cox-proportional hazard models, based on the same set of patients and using the same confounders as reported by the original studies, were used to determine overall, cancer-specific, or relapse-free survival for each subtype. Hazard ratios and confidence intervals, as well as Kaplan-Meier plots were compared to those reported by the original studies.

Results: We observed similar patterns of worse survival for the microsatellite stable (MSS)/BRAF-mutated and MSS/KRAS-mutated subtypes in our validation analyses, which were included in two of the validated classifications. Of the two MSI subtypes, one defined by additional presence of CIMP-high and BRAF-mutation and the other by tumors negative for CIMP, BRAF and KRAS-mutations, we could not confirm associations with better prognosis as suggested by one of the classifications. For two of the published classifications, we were able to provide results for additional subgroups not included in the original studies (men, other disease stages, other locations).

Conclusions: External validation of three previously proposed classifications confirmed findings of worse survival for CRC patients with MSS subtypes and BRAF or KRAS mutations. Regarding MSI subtypes, other patient characteristics such as stage of the tumor, may influence the potential survival benefit. Further integration of methylation, genetic, and immunological information is needed to develop and validate a comprehensive classification that will have relevance for use in clinical practice.

Item Type: Article
Journal or Publication Title: BMC Cancer
Volume: 19
Number: 681
Publisher: BioMed Central ; Springer
Place of Publication: London ; Berlin, Heidelberg
Date Deposited: 13 Aug 2019 09:00
Date: 2019
ISSN: 1471-2407
Page Range: pp. 1-10
Faculties / Institutes: Service facilities > German Cancer Research Center (DKFZ)
Medizinische Fakultät Heidelberg > Pathologisches Institut
Subjects: 610 Medical sciences Medicine
Uncontrolled Keywords: Colorectal cancer, Molecular subtypes, Cancer-specific survival, External validation
About | FAQ | Contact | Imprint |
OA-LogoDINI certificate 2013Logo der Open-Archives-Initiative